Amgen and Adaptive Biotechnologies Announce Strategic Partnership to Develop a Therapeutic to Prevent or Treat COVID-19
By: Colorado BioScience Association Date: 04/02/2020
Amgen (NASDAQ:AMGN) and Adaptive Biotechnologies (NASDAQ:ADPT) today announced a collaboration aimed at helping address the COVID-19 pandemic. The companies will combine expertise to discover and deve...
Learn MoreAktivax, Inc. has been awarded a $16 million contract from the Biomedical Advanced Research and Development Authority (BARDA)
By: Colorado BioScience Association Date: 04/01/2020
Shortly after receiving a $24.5 million project from the Department of Defense (DOD) to develop a scopolamine auto-injector, Aktivax, Inc. has been awarded a $16 million contract from the Biomedical A...
Learn MoreFlagship Biosciences Hires New Vice President of Clinical Diagnostics
By: Colorado BioScience Association Date: 03/31/2020
Flagship Biosciences, providers of expert tissue data insights, today announced that Geoff Metcalf, MBA, PMP, will join its executive team as Vice President Clinical Diagnostics. Geoff brings 25 years...
Learn MoreSOPHiA GENETICS and Paragon Genomics Join Forces Against COVID-19 Coronavirus Pandemic
By: Colorado BioScience Association Date: 03/26/2020
SOPHiA GENETICS, leader in Data-Driven Medicine, today announced that it is entering the fight against the COVID-19 coronavirus by extending its partnership with Paragon Genomics, who developed a next...
Learn MoreAktivax, Inc. Awarded a $24.5M US Government Project
By: Colorado BioScience Association Date: 03/25/2020
Aktivax, Inc. has been awarded a $24.5 million US government project to develop an autoinjector treatment for exposure to nerve agents. The award is an Other Transaction (OT) prototype project by the...
Learn MorePharmaJet Received Multi-Year, Multi-Million Dollar Award to Support Next-Generation Needle-free Delivery Devices
By: Colorado BioScience Association Date: 03/18/2020
PharmaJet®, the maker of innovative, needle-free injection technology, announced that it received a $9.6 million dollar contract award from the Joint Science and Technology Office of the U.S. Defense...
Learn MorePfizer Outlines Five-Point Plan to Battle COVID-19
By: Colorado BioScience Association Date: 03/17/2020
Chairman and CEO Albert Bourla Calls on Biopharma Industry to Collaborate on Combatting the Global Pandemic. Read the plan here.
Learn MoreBiodesix Announces New Commercial Organization and Executive Appointments
By: Colorado BioScience Association Date: 03/10/2020
Biodesix, Inc., a leading diagnostic company in lung cancer, today announced the realignment of their commercial executive team. Kieran O’Kane will be promoted to Chief Commercial Officer (CCO) and Bo...
Learn MoreCSU, Zoetis leaders herald launch of new research lab
By: Colorado BioScience Association Date: 01/30/2020
Officials from Zoetis, the world’s leading animal health company, and Colorado State University gathered on the Foothills Campus on Jan. 28 to celebrate the opening of a new lab. The 3,000-square-foot...
Learn MoreNew Investments Boost Colorado's Life Sciences Community
By: Colorado BioScience Association Date: 01/23/2020
The Rockies Venture Club and Colorado BioScience Association (CBSA) announced a partnership to mobilize Colorado’s capital resources to support early-stage bioscience companies in the state. “Co...
Learn More